Skip to main content
. Author manuscript; available in PMC: 2017 Oct 25.
Published in final edited form as: Am J Cardiol. 2015 Aug 31;116(10):1509–1515. doi: 10.1016/j.amjcard.2015.08.012

Table 1.

Baseline characteristics and angiographic data categorized based on METs achieved

Variable Exercise Work Load (N = 1,052)
P value between MET categories
<7 METs (N=464)
P value ≥7 METs (N=588)
P value
PCI+OMT
(N=241)
OMT
(N=223)
PCI+OMT
(N=286)
OMT
(N=302)
Age (years) mean ± SD 64 ± 9 65 ± 9 0.30 59 ± 9 58 ± 9 0.23 <0.001*
Men 187 (78%) 173 (78%) 1.00 258 (90%) 281 (93%) 0.21 <0.001*
White 209 (87%) 196 (88%) 0.78 262 (92%) 256 (86%) 0.03 0.67
BMI mean ± SD (kg/m2) 30 ± 5 29 ± 5 0.13 29 ± 4 29 ± 5 0.75 0.11
Never smoked 48 (20%) 52 (23%) 0.37 54 (19%) 74 (25%) 0.10 0.93
Hypertension 152 (63%) 136 (62%) 0.74 164 (59%) 172 (58%) 0.84 0.14
Diabetes mellitus 72 (30%) 60 (27%) 0.50 66 (23%) 85 (29%) 0.15 0.34
Family history of CAD 106 (48%) 88 (44%) 0.36 153 (58%) 157 (56%) 0.65 <0.001*
Myocardial infarction 68 (29%) 76 (35%) 0.17 97 (34%) 96 (32%) 0.64 0.54
CABG 17 (7%) 21 (9%) 0.35 27 (9%) 19 (6%) 0.16 0.83
PCI 35 (15%) 19 (9%) 0.04 40 (14%) 44 (15%) 0.85 0.21
Angina pectoris 217 (90%) 200 (90%) 0.79 241 (85%) 256 (85%) 0.94   0.01*
CCS Angina Class 0 23 (10%) 23 (10%) 0.46 44(15%) 46 (15%) 0.12 <0.001*
1 57 (24%) 58 (26%) 89 (31%) 104 (34%)
2 94 (39%) 95(43%) 106(37%) 123 (41%)
3 66 (28%) 47 (21%) 46 (16%) 29 (10%)
PAD 17 (7%) 10 (5%) 0.25 9 (3%) 13 (4%) 0.46 0.11
Heart failure 6 (3%) 6 (3%) 0.88 14 (5%) 7 (2%) 0.09 0.36
Stroke/TIA 15 (6%) 15 (7%) 0.84 13 (5%) 20 (7%) 0.28 0.55
Renal disease 5 (2%) 0 0.03 6 (2%) 7 (2%) 0.86 0.16
Heart rate (bpm) mean ± SD 64 ± 10 66 ± 13 0.08 64 ±11 65 ± 11 0.39 0.64
SBP (mm Hg) mean ± SD 135 ± 21 134 ± 18 0.71 131 ± 18 130 ± 18 0.50     0.002*
DBP (mm Hg) mean ± SD 64 ± 11 73 ± 11 0.83 76 ± 11 76 ± 11 0.99 <0.001*
Number of arteries narrowed 1 80 (33%) 65 (29%) 0.28 105 (37%) 99 (33) 0.61 0.49
2 100 (41%) 87 (39%) 105 (37%) 118 (39%)
3 61 (25%) 71 (32%) 76 (27%) 85 (28%)
Ejection Fraction 63 ± 11% 63 ± 10% 0.55 63 ± 11% 62 ± 9% 0.54 0.28
Medications (n) 206 183 233 247
Aspirin 185 (90%) 167 (91%) 0.63 202 (87%) 216 (87%) 0.81 0.12
ACEi/ARB 101 (49%) 89 (49%) 0.98 115 (49%) 123 (50%) 0.85 0.89
Beta-blocker 155 (75%) 129 (71%) 0.33 165(70%) 176 (71%) 0.80 0.44
Calcium channel blocker 72 (35%) 60 (33%) 0.68 59 (25%) 61 (25%) 0.92     0.003*

ACEi = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; BMI = body mass index; CAD = coronary artery disease; CABG = coronary artery bypass grafting; CCS = Canadian Cardiovascular Class; DBP = diastolic blood pressure; METs = metabolic equivalents; OMT = optimal medical therapy; PAD = peripheral arterial disease; PCI = percutaneous coronary intervention; SBP = systolic blood pressure; SD = standard deviation; TIA = transient ischemic attack.

*

p <0.01 significant.